BIIB vs LFUS · P/E 21, rev $9.89B vs rev $2.39B
Biogen Inc (BIIB) versus Littelfuse Inc (LFUS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Littelfuse Inc (LFUS) is a electronic components company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported LFUS revenue for 2025-12-27 was $2.39B. Net income was -$71.7M. Revenue was up 8.9% from 2024-12-28 to 2025-12-27. LFUS currently screens at market cap $11.80B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. LFUS currently screens at market cap $11.80B.
Not investment advice. Open the BIIB and LFUS stock pages for the full models.
Not investment advice.